PREDNISONE VERSUS DEFLAZACORT IN THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIC PURPURA: EVALUATON OF CLINICAL RESPONSE AND IMMUNOLOGICAL MODIFICATIONS

MLA

A, Ferrari, et al. Prednisone Versus Deflazacort in the Treatment of Autoimmune Thrombocytopenic Purpura: Evaluaton of Clinical Response and Immunological Modifications. Jan. 1991. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....a11f2792ca3b983384fc28a93019f797&authtype=sso&custid=ns315887.

APA

A, F., D, P., P, D. B., G M, G., A, C., & M G, M. (1991). Prednisone Versus Deflazacort in the Treatment of Autoimmune Thrombocytopenic Purpura: Evaluaton of Clinical Response and Immunological Modifications.

Chicago

A, Ferrari, Pasqualetti D, Del Bianco P, Gandolfo G M, Chistolini A, and Mazzucconi M G. 1991. “Prednisone Versus Deflazacort in the Treatment of Autoimmune Thrombocytopenic Purpura: Evaluaton of Clinical Response and Immunological Modifications,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....a11f2792ca3b983384fc28a93019f797&authtype=sso&custid=ns315887.